Cargando…
Management of Elderly Patients with Glioblastoma after CE.6
Autores principales: | Das, Sunit, Kim, Albert H., Chang, Susan, Berger, Mitchel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582080/ https://www.ncbi.nlm.nih.gov/pubmed/28913179 http://dx.doi.org/10.3389/fonc.2017.00196 |
Ejemplares similares
-
Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial
por: Das, Sunit, et al.
Publicado: (2020) -
Editorial: Contemporary Management of Intracranial Metastatic Disease
por: Das, Sunit, et al.
Publicado: (2019) -
Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017) -
Molecular Characteristics in MRI-Classified Group 1 Glioblastoma Multiforme
por: Haskins, William E., et al.
Publicado: (2013) -
Metabolic management of microenvironment acidity in glioblastoma
por: Seyfried, Thomas N., et al.
Publicado: (2022)